Healthequity, Inc. HQY
3 trading plans running, 36 Form 144 notices for $12.8M
10-Q, 10-K and Form 144What HQY's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Sep 22, 2023 to Feb 1, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Gayle Wellborn member of our board of directors |
Adopted 10b5-1 plan | Jan 14, 2026 | 10-K Mar 17, 2026 | ||
What the company wroteOn January 14, 2026, Gayle Wellborn, a member of our board of directors, entered into a Rule 10b5-1 trading arrangement (the “Wellborn Arrangement”). The Wellborn Arrangement provides for the sale, between April 15, 2026 and December 31, 2026, of up to 2,439 shares of the Company’s common stock held by Ms. Wellborn. The Wellborn Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Adrian Dillon member of our board of directors |
Adopted 10b5-1 plan | Dec 20, 2025 | 10-K Mar 17, 2026 | ||
What the company wroteOn December 20, 2025, Adrian Dillon, a member of our board of directors, entered into a Rule 10b5-1 trading arrangement (the “Dillon Arrangement”). The Dillon Arrangement provides for the sale, between March 21, 2026 and February 1, 2027, of up to 12,469 shares of the Company’s common stock held by Mr. Dillon, which represent the exercise of expiring stock options and sale of the underlying shares. The Dillon Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Michael Fiore Executive Vice President and Chief Commercial Officer, |
Adopted 10b5-1 plan | Oct 14, 2025 | 10-Q Dec 3, 2025 | ||
What the company wroteOn October 14, 2025, Michael Fiore, our Executive Vice President and Chief Commercial Officer, entered into a Rule 10b5-1 trading arrangement (the “Fiore Arrangement”). The Fiore Arrangement provides for the sale, between January 13, 2026 and December 15, 2026, of up to 19,532 aggregate shares of the Company’s common stock held directly by Mr. Fiore. The Fiore Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Delano Ladd Executive Vice President, General Counsel and Secretary |
Adopted 10b5-1 plan | Jun 12, 2025 | 10-Q Sep 2, 2025 | ||
What the company wroteOn June 12, 2025, Delano Ladd, our Executive Vice President, General Counsel and Secretary, entered into a Rule 10b5-1 trading arrangement (the “Ladd Arrangement”). The Ladd Arrangement provides for the sale, between September 11, 2025 and June 6, 2026, of up to 18,000 aggregate shares of the Company’s common stock held directly by Mr. Ladd. The Ladd Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Stephen Neeleman Founder and Vice Chairman |
Adopted 10b5-1 plan | Jun 9, 2025 | 10-Q Sep 2, 2025 | ||
What the company wroteOn June 9, 2025, Stephen Neeleman, our Founder and Vice Chairman, entered into a Rule 10b5-1 trading arrangement (the “Neeleman Arrangement”). The Neeleman Arrangement provides for the sale, between September 9, 2025 and September 11, 2026, of up to 54,356 aggregate shares of the Company’s common stock held directly and indirectly by Dr. Neeleman. The Neeleman Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Michael Fiore Chief Commercial Officer |
Adopted 10b5-1 plan | Dec 18, 2024 | 10-K Mar 18, 2025 | ||
What the company wroteOn December 18, 2024, Michael Fiore, our Chief Commercial Officer, entered into a Rule 10b5-1 trading arrangement (the “Fiore Arrangement”). The Fiore Arrangement provides for the sale, between March 19, 2025 and December 15, 2025, of up to 20,580 aggregate shares of the Company’s common stock held by Mr. Fiore. The Fiore Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Robert Selander chairman of our board of directors |
Adopted 10b5-1 plan | Jul 9, 2024 | 10-Q Sep 3, 2024 | ||
What the company wroteOn July 9, 2024, Robert Selander, chairman of our board of directors, entered into a Rule 10b5-1 trading arrangement (the “Selander Arrangement”). The Selander Arrangement provides for the sale, between October 9, 2024 and April 16, 2025, of up to 28,000 aggregate shares of the Company’s common stock held directly by Mr. Selander and the exercise of up to 65,000 stock options. The Selander Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Jon Kessler President and Chief Executive Officer |
Adopted 10b5-1 plan | Mar 25, 2024 | 10-Q Jun 3, 2024 | ||
What the company wroteOn March 25, 2024, Jon Kessler, our President and Chief Executive Officer, entered into a Rule 10b5-1 trading arrangement (the “Kessler Arrangement”). The Kessler Arrangement provides for the sale, between June 24, 2024 and November 29, 2024, of up to 85,000 aggregate shares of the Company’s common stock held directly or indirectly by Mr. Kessler. The Kessler Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Stephen Neeleman Founder and Vice Chairman |
Adopted 10b5-1 plan | Dec 8, 2023 | 10-K Mar 22, 2024 | ||
What the company wroteOn December 08, 2023, Stephen Neeleman, our Founder and Vice Chairman, entered into a Rule 10b5-1 trading arrangement (the “Neeleman Arrangement”). The Neeleman Arrangement provides for the sale, between December 8, 2023 and July 31, 2024, of up to 70,000 aggregate shares of the Company’s common stock held directly by Dr. Neeleman. The Neeleman Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Delano Ladd Executive Vice President, General Counsel and Secretary |
Adopted 10b5-1 plan | Sep 22, 2023 | 10-K Mar 22, 2024 | ||
What the company wroteOn September 22, 2023, Delano Ladd, our Executive Vice President, General Counsel and Secretary, entered into a Rule 10b5-1 trading arrangement (the “Ladd Arrangement”). The Ladd Arrangement provides for the sale, between December 22, 2023 and August 30, 2024, of up to 7,643 aggregate shares of the Company’s common stock held directly by Mr. Ladd. The Ladd Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
| Delano Ladd Executive Vice President, General Counsel and Secretary |
Adopted 10b5-1 plan | Sep 22, 2023 | 10-Q Dec 5, 2023 | ||
What the company wroteOn September 22, 2023, Delano Ladd, our Executive Vice President, General Counsel and Secretary, entered into a Rule 10b5-1 trading arrangement (the “Ladd Arrangement”). The Ladd Arrangement provides for the sale, between December 22, 2023 and August 30, 2024, of up to 7,643 aggregate shares of the Company’s common stock held directly by Mr. Ladd. The Ladd Arrangement was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. | |||||
Show the other 3 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 14 filings checked since Jun 7, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Oct 8, 2026 | Michael Gathright Officer |
662 | $60K |
| Oct 8, 2026 | Michael Henry Fiore Former EVP, CCO |
2,032 | $185K |
| Oct 8, 2026 | Scott Cutler Officer, Director |
1,230 | $112K |
| Oct 8, 2026 | Delano Ladd Officer |
1,080 | $98K |
| Oct 8, 2026 | James M. Lucania Officer |
2,822 | $257K |
| Oct 8, 2026 | Stephen Neeleman Officer, Director |
1,095 | $100K |
| Aug 25, 2026 | ADRIAN DILLON Director |
7,632 | $804K |
| Jul 13, 2026 | Michael Gathright Officer |
2,270 | $211K |
| Jul 10, 2026 | Michael Henry Fiore Officer |
2,045 | $194K |
| Jul 10, 2026 | MICHAEL FIORE Officer |
2,354 | $223K |
| Jul 10, 2026 | Scott Cutler Officer, Director |
1,238 | $118K |
| Jul 10, 2026 | Delano Ladd Officer |
1,087 | $103K |
| Jul 10, 2026 | James M. Lucania Officer |
2,839 | $270K |
| Jul 10, 2026 | Stephen Neeleman Officer, Director |
1,103 | $105K |
| Jul 2, 2026 | MICHAEL FIORE Officer |
2,470 | $228K |
| May 29, 2026 | MICHAEL FIORE Officer |
3,142 | $284K |
| May 28, 2026 | GAYLE WELLBORN Director |
2,439 | $211K |
| May 28, 2026 | DELANO LADD Officer |
7,500 | $649K |
| Apr 8, 2026 | Michael Henry Fiore Officer |
3,378 | $283K |
| Apr 8, 2026 | Elimelech Rosner Officer |
4,768 | $400K |
| Apr 8, 2026 | Scott Cutler Officer, Director |
4,931 | $413K |
| Apr 8, 2026 | Delano Ladd Officer |
2,481 | $208K |
| Apr 8, 2026 | James M. Lucania Officer |
4,393 | $368K |
| Apr 8, 2026 | Stephen Neeleman Officer, Director |
2,559 | $215K |
| Apr 2, 2026 | Elimelech Rosner Officer |
18,010 | $1.5M |
| Apr 2, 2026 | Delano Ladd Officer |
7,726 | $638K |
| Apr 2, 2026 | Stephen Neeleman Officer, Director |
9,292 | $767K |
| Jan 14, 2026 | Scott Cutler Officer, Director |
12,496 | $1.1M |
| Jan 13, 2026 | Michael Henry Fiore Officer |
1,744 | $166K |
| Jan 13, 2026 | Elimelech Rosner Officer |
2,074 | $198K |
| Jan 13, 2026 | Delano Ladd Officer |
739 | $70K |
| Jan 13, 2026 | James M. Lucania Officer |
2,470 | $235K |
| Jan 13, 2026 | Stephen Neeleman Officer, Director |
791 | $75K |
| Dec 19, 2025 | DELANO LADD Officer |
4,500 | $430K |
| Dec 18, 2025 | ELIMELECH ROSNER Officer |
10,959 | $1.0M |
| Dec 12, 2025 | GAYLE F WELLBORN Director |
4,339 | $425K |
Show the other 28 notices
From the Form 144 XML filed with the SEC, since Dec 12, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HQY/export.csv") into a cell.